Table 1 Patient Characteristics
Variables | 59.2–60.8 GyE/16 Fx (n = 46) | 66 GyE/24 Fx (n = 18) | P |
|---|---|---|---|
Age, median year (IQR) | 70.5 (66, 76) | 73 (66,77) | 0.57 |
NCCN Stage- No. (%) | 0.60 | ||
 Low risk | 3 (6.5) | 0 (0) |  |
 Middle risk | 16 (34.8) | 8 (44.4) |  |
 High risk | 19 (41.3) | 8 (44.4) |  |
 Very high risk | 8 (17.4) | 2 (11.1) |  |
T stage- No. (%) | |||
 1-2a | 9 (19.6) | 6 (33.3) | 0.26 |
 2b-2c | 28 (60.9) | 11 (61.1) |  |
 3–4 | 9 (19.6) | 1 (5.6) |  |
PSA vertices -No. (%) | |||
 < 10 ng/ml | 18 (39.1) | 6 (33.3) | 0.88 |
 10–20 ng/ml | 13 (28.3) | 5 (27.8) |  |
 > 20 ng/ml | 15 (32.6) | 7 (38.9) |  |